Abstract
To evaluate the occurrence of complications during diagnostic or interventional catheterization a retrospective analysis of catheterization procedures in 1.2 italian laboratories using the nonionic contrast medium (CM) iopamidol (370mgI/ml) was performed. Data obtained on 26,219 patients ≥ 14 years are presented. The overall complication rate was 1.89% (485/26,219). The overall mortality rate was 0.1% (27/26,219). Procedure related complications were 389 (1.48%) and CM related complications were 106 (0.4%). No death was attributed to CM. Ventricular fibrillation (VF) rate was 0.11% comparable to the low rate observed with nonionic CM in other studies and less than the rate observed in surveys concerning the use of ionic CM. Fifty-seven thrombotic events were recorded (0.22%), a rate comparable with other surveys with ionic and nonionic CM. The total complication rate (6.1%), the rates of coronary occlusion (1.34%), myocardial infarction (0.37%) and urgent coronary artery by-pass grafting (0.5%) in 1,348 coronary angioplasties were lower than those recorded in previous surveys.
These data confirm a good tolerability and no increased risk of VF and thrombotic events with iopamidol in cardiac catheterization.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CM:
-
contrast medium
- VF:
-
ventricular fibrillation
References
Katayama H, Kozuka T, Takashima T, Matsuura K, Seex P, Yamaguchi K. Adverse reactions to ionic and non ionic contrast media. A Report from the Japanese Committee on the safety of contrast media. Radiology 1990; 175: 621–8.
Palmer FJ. The R.A. C.R. survey of intravenous contrast media reactions. Final report. Australas Radiol 1988; 32: 426–8.
Grollman JH, Liu CK, Astone RA, Lurie MD. Thromboembolic complications in coronary angiography associated with the use of nonionic contrast medium. Cathet Cardiovasc Diagn 1988; 14: 159–64.
Robertson HJF. Grollman JH. Thromboembolic complications in coronary angiography associated with the use of nonionic contrast medium. Cathet Cardiovac Diagn 1988; 16: 145–6.
Hayakawa K, Yamashita K. Contrast media-induced ventricular fibrillation. Invest Radiol 1987; 23: 144–6.
Morris TW. Ventricular fibrillation during right coronary arteriography with ioxaglate, iohexol and iopamidol in dogs. Invest Radiol 1988; 23: 205–8.
Kennedy JW. Complications associated with cardiac catheterization and angiography. Cathet Cardiovas Diagn 1982; 8: 5–11.
Johnson LW, Lozner EC, Johnson S, Krone R, Pichard AD, Vetrovec GW, Noto TJ. Coronary arteriography 1984–1987: a report of the registry of the Society for Cardiac Angiography and Interventions. I. Results and complications. Cathet Cardiovasc Diagn 1989; 17: 5–10.
Adams DF, Fraser DB, Abrams HL. The complications of coronary arteriography. Circulation 1973; 58: 609–18.
Adams DF, Abrams HL. Complications of coronary arteriography: a follow-up report. Cardiovas Radiol 1979; 2: 89–96.
Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization — A prospective trial. Ann Intern Med 1989; 110: 119–24.
Bashore TM, Davidson CJ, Mark DB, Kisslo K, Hlatky ARCVTM, Skelton TN. Iopamidol use in the cardiac catheterization laboratory: a retrospective analysis of 3.313 patients. Cardio 1988; 5(3) 2: 6–10.
Davidson CJ, Mark DB, Pieper KS, Kisslo KB, Hlatky MA, Gabriel DA, Bashore TM. Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: Analysis of 8,517 patients. Am J Cardiol 1990; 65: 1481–4.
Levorstad K, Vatne U, Brodahl B, Laake S, Simonsen, Aakhus T. Safety of the nonionic contrast medium Omnipaque in coronary angiography. Cardiovas Intervent Radiol 1989; 12: 98–100.
Oldroyd KG, Phadke KV, Carson PHM, Clarke M, Davis JAS. Cardiac catheterization by the Judkins technique as an outpatient procedure. Br Med J 1989; 298: 875–6.
Holmes DR Jr, Holukov R, Vlietstra MS, Kelsey FMBChBS, Reeder GS, Dorros G, et al. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: The national heart, lung and blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol 1988; 12(5): 1149–55.
Dorros G, Cowley MJ, Simpson J, Bentivoglio LG, Block PC, Bourassa M, et al. Percutaneous transluminal coronary angioplasty: report of complications from the national heart, lung, and blood Institute PTCA Registry. Circulation 1983; 67(4): 723–30.
Bernard M, Foult JM, Lefevre T, Ricolfi F. Analyse des complications de la coronarographie. A propos d'une serie de 2300 examens consecutifs. J Radiol 1987; 68(5): 353–60.
Hildner FJ, Javier RP, Ramaswamy K, Samet P. Pseudo complications of cardiac catheterization. Chest 1973; 63(1): 15–7.
Hayakawa K, Yamashita K. Low osmolality contrast media induced ventricular fibrillation. Invest Radiol 1989; 24: 298–301.
Hwang MH, Piao ZE, Murdock DK, Messmore HL, Giardina JJ, Scanion PJ. Risk of thromboembolism during diagnostic and interventional cardiac procedures with nonionic contrast media. Radiology 1990; 174: 453–7.
Farced J, Walenga JM, Stravia GE, Moncada RM. Thrombogenic potential of nonionic contrast media? Radiology 1990; 174: 321–5.
Gasperetti CM, Feldman MD, Burwell LR. Nonionic contrast material is associated with thrombus formation during PTCA [abstract]. Circulation 1989; 80 Suppl II: 375A.
Rights and permissions
About this article
Cite this article
Ballerini, L., Barbaresi, F., Binaghi, G. et al. Iopamidol in cardioangiography: a retrospective, multicenter study. Int J Cardiac Imag 8, 35–43 (1992). https://doi.org/10.1007/BF01137564
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01137564